Results 211 to 220 of about 3,022,233 (266)

Correction for Meireles et al., Aging populations threaten conservation goals of zoos. [PDF]

Proc Natl Acad Sci U S A
europepmc   +1 more source

Early Eocene Palynofloral Diversity and <i>Nothofagus</i> Niche Modeling Across Western Gondwana. [PDF]

Plants (Basel)
Hinojosa LF, Carvajal FM, Quattrocchio M, Fernández DA, Pérez MF.   +4 more
europepmc   +1 more source

Validation of a Genetic Risk Score Combined With Clinical Variables for Predicting Pulmonary Fibrosis in Early Rheumatoid Arthritis

Arthritis Care &Research, EarlyView.
Objective Pulmonary fibrosis (PF) is a severe extra‐articular manifestation of rheumatoid arthritis (RA). This study aimed to externally validate a genetic risk score (GRS) and a combined risk score (CRS) for predicting the risk of RA‐associated PF in an independent cohort of patients with early RA.
Mikael Brink, Austin Wheeler, Bryant R. England, Solbritt Rantapää‐Dahlqvist   +3 more
wiley   +1 more source

Corrigendum to "American Epilepsy Society/International League Against Epilepsy-North America Joint Task Force for Epilepsy Health Care Disparities in the United States." [PDF]

Epilepsy Curr
europepmc   +1 more source

From informal practice to structured care: pharmaceutical indication and minor ailment management in Latin American community pharmacy. [PDF]

Front Public Health
Zavaleta-Monestel E, Gómez-Martínez JC, Martínez-Martínez F, Escudero-Correa A, Soderlund LA, Mora-Jiménez J, Arguedas-Chacón S.   +6 more
europepmc   +1 more source

Limitations of Complement Activity Assays as Biomarkers for Ravulizumab Therapeutic Monitoring

Annals of Clinical and Translational Neurology, EarlyView.
Francesco Saccà, Ryan Pelto
wiley   +1 more source

Performance Characteristics of Anti–Collagen II Antibodies in Relapsing Polychondritis and Related Diseases: Prospective Analysis, Systematic Review, and Meta‐Analysis

Arthritis Care &Research, EarlyView.
Objective Relapsing polychondritis (RP) is a rare disease defined by recurrent cartilaginous inflammation. Anti–collagen II (Col2) antibodies have been proposed as a diagnostic biomarker for RP, but their performance characteristics are not well defined.
Karyssa Stonick, Marcela A. Ferrada, Alice Fike, Kaitlin A. Quinn, Benjamin A. Turturice, Casey Stein, Peter C Grayson   +6 more
wiley   +1 more source

Abusive head trauma in children under 2 years of age in Latin America: a systematic review. [PDF]

Childs Nerv Syst
Melo JRT, Fernandes MAC, Giordano JC, Leal IZ, de Almeida Chaves CV, Veiga JCE.   +5 more
europepmc   +1 more source

Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Belimumab in Pediatric Patients With Systemic Lupus Erythematosus: A Multicenter, Open‐Label Trial

Arthritis Care &Research, EarlyView.
Objective This study aimed to characterize the pharmacokinetics, pharmacodynamics, safety, and exploratory efficacy of subcutaneous belimumab in pediatric patients with active systemic lupus erythematosus (SLE) receiving standard therapy. Methods This single‐arm, multicenter, open‐label trial (GSK study 200908; ClinicalTrials.gov identifier ...
Hermine I. Brunner, Jordi Antón, Inmaculada Calvo‐Penadés, Richard Dimelow, Gerd Horneff, Sylvia Kamphuis, Rebecca Marino, Andre van Maurik, Kirsten Minden, Masaaki Mori, Josephine Ocran‐Appiah, Christel Wilkinson, Yuichi Yamasaki, Deepak Assudani, for the Pediatric Rheumatology Collaborative Study Group (PRCSG) and Paediatric Rheumatology International Trials Organisation (PRINTO) Network investigators   +14 more
wiley   +1 more source

A worldwide perspective on clinical characteristics and treatment of youth with monogenic diabetes in the SWEET registry. [PDF]

J Endocr Soc
Deng L, Lanzinger S, Casteels K, Cavallo F, De Sanctis L, Fitas AL, Huang C, Kim J, Patouni K, Pruhova S, Taplin CE, Tauschmann M, Krishnamurthy M.   +12 more
europepmc   +1 more source